Sports Medicine

, Volume 30, Issue 3, pp 155–170 | Cite as

Adverse Effects of Creatine Supplementation

Fact or Fiction?
  • Jacques R. Poortmans
  • Marc Francaux
Leading Article


The consumption of oral creatine monohydrate has become increasingly common among professional and amateur athletes. Despite numerous publications on the ergogenic effects of this naturally occurring substance, there is little information on the possible adverse effects of this supplement. The objectives of this review are to identify the scientific facts and contrast them with reports in the news media, which have repeatedly emphasised the health risks of creatine supplementation and do not hesitate to draw broad conclusions from individual case reports.

Exogenous creatine supplements are often consumed by athletes in amounts of up to 20 g/day for a few days, followed by 1 to 10 g/day for weeks, months and even years. Usually, consumers do not report any adverse effects, but body mass increases. There are few reports that creatine supplementation has protective effects in heart, muscle and neurological diseases. Gastrointestinal disturbances and muscle cramps have been reported occasionally in healthy individuals, but the effects are anecdotal. Liver and kidney dysfunction have also been suggested on the basis of small changes in markers of organ function and of occasional case reports, but well controlled studies on the adverse effects of exogenous creatine supplementation are almost nonexistent.

We have investigated liver changes during medium term (4 weeks) creatine supplementation in young athletes. None showed any evidence of dysfunction on the basis of serum enzymes and urea production. Short term (5 days), medium term (9 weeks) and long term (up to 5 years) oral creatine supplementation has been studied in small cohorts of athletes whose kidney function was monitored by clearance methods and urine protein excretion rate. We did not find any adverse effects on renal function.

The present review is not intended to reach conclusions on the effect of creatine supplementation on sport performance, but we believe that there is no evidence for deleterious effects in healthy individuals. Nevertheless, idiosyncratic effects may occur when large amounts of an exogenous substance containing an amino group are consumed, with the consequent increased load on the liver and kidneys. Regular monitoring is compulsory to avoid any abnormal reactions during oral creatine supplementation.


Amyotrophic Lateral Sclerosis Creatine Myofibrillar Protein Creatine Supplementation Muscle Cramp 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We are indebted to the Direction Générale des Sports (Communauté Française de Belgique) for their support and to Flamma SpA (Italy) who provided the creatine monohydrate. We also thank Mrs F. Louppe-Reding, Mrs V. Godaert and Mr J. Michotte de Welle for their efficient technical help.


  1. 1.
    Williams M, Branch J. Creatine supplementation and exercise performance: an update. J Am Coll Nutr 1998; 17: 216-34PubMedGoogle Scholar
  2. 2.
    Balsom PD, Söderlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med 1994; 18: 268–80PubMedGoogle Scholar
  3. 3.
    Bigard A. Effets ergogéniques de la créatine. Sci Sports 1998; 13: 211–20Google Scholar
  4. 4.
    Ekblom B. Effects of creatine supplementation and exercise performance. Am J Sports Med 1996; 24: S38–9PubMedGoogle Scholar
  5. 5.
    Greenhaff P. Creatine and its application as an ergogenic aid. Int J Sport Nutr 1995; 5: S100–10PubMedGoogle Scholar
  6. 6.
    Juhn M, Tarnopolsky M. Oral creatine supplementation and athletic performance: a critical review. Clin J Sport Med 1998; 8: 286–97PubMedGoogle Scholar
  7. 7.
    Maughan R. Creatine supplementation and exercise performance. Int J Sport Nutr 1995; 5: 94–101PubMedGoogle Scholar
  8. 8.
    Mujika I, Padilla S. Creatine supplementation as an ergogenic aid for sports performance in highly trained athletes: a critical review. Int J Sports Med 1997; 18: 491–6PubMedGoogle Scholar
  9. 9.
    Conway MA, Clark JF. Creatine and creatine phosphate: scientific and clinical perspectives. San Diego (CA): Academic Press, 1996Google Scholar
  10. 10.
    Williams MH, Kreider RB, Branch JD. Creatine: the power supplement. Champaign (IL): Human Kinetics, 1999Google Scholar
  11. 11.
    Juhn MS, Tarnopolsky M. Potential side effects of oral creatine supplementation: a critical review. Clin J Sport Med 1998; 8: 298–304PubMedGoogle Scholar
  12. 12.
    Demant TW, Rhodes EC. Effects of creatine supplementation on exercise performance. Sports Med 1999; 28: 49–60PubMedGoogle Scholar
  13. 13.
    Miquel P. Le sport Américain a cédé aux charmes de la créatine. Le Monde 1998 Aug 14: 15Google Scholar
  14. 14.
    Schneider K, Hervig L, Ensign WY, et al. Use of supplements by US Navy Seals [abstract]. Med Sci Sports Exerc 1998; 30: S60Google Scholar
  15. 15.
    Haris N, Arthur C. Anatomy of a ‘miracle’ substance. The Independent 1998 Dec 8: 4Google Scholar
  16. 16.
    American College of Sports Medicine Roundtable. The physiological and health effects of oral creatine supplementation. Med Sci Sports Exerc 2000 Mar; 32 (3): 706–17Google Scholar
  17. 17.
    Pritchard NR, Kalra PA. Renal dysfunction accompanying oral creatine supplements. Lancet 1998; 351: 1252–3PubMedGoogle Scholar
  18. 18.
    La créatine dangereuse? L’Equipe 1998 Apr 28: 10Google Scholar
  19. 19.
    Nau J-K. La créatine, produit curieux aux effets étranges. Le Monde 1998 Nov 21: 24Google Scholar
  20. 20.
    Daulouède C. L’envers de la créatine. Sport et Vie 1998 Nov: 58Google Scholar
  21. 21.
    Haget H. Des sportifs gonflés. Le Vif/L’Express 1998 Oct 30: 114Google Scholar
  22. 22.
    US Food and Drug Administration. The special nutritionals adverse event monitoring system. Available from: [Accessed 2000 Jun 21]Google Scholar
  23. 23.
    Balsom P, Ekblom B, Söderlund K, et al. Creatine supplementation and dynamic high-intensity intermittent exercise. Scand J Med Sci Sports 1993; 3: 143–9Google Scholar
  24. 24.
    Balsom P, Harridge S, Söderlund K, et al. Creatine supplementation per se does not enhance endurance exercise performance. Acta Physiol Scand 1993; 149: 521–3PubMedGoogle Scholar
  25. 25.
    Greenhaff P, Bodin K, Söderlund K, et al. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 1994; 266: E724–30Google Scholar
  26. 26.
    Stroud M, Holliman D, Bell D, et al. Effect of oral creatine supplementation on respiratory gas exchange and blood lactate accumulation during steady-state incremental treadmill exercise and recovery in man. Clin Sci 1994; 87: 707–10PubMedGoogle Scholar
  27. 27.
    Balsom P, Söderlund K, Sjödin B, et al. Skeletal muscle metabolism during short duration high-intensity exercise: influence of creatine supplementation. Acta Physiol Scand 1995; 154: 303–10PubMedGoogle Scholar
  28. 28.
    Dawson B, Cutler M, Moody A, et al. Effects of oral creatine loading on single and repeated maximal short sprints. Aust J Sci Med Sport 1995; 27: 56–61PubMedGoogle Scholar
  29. 29.
    Green A, Hultman E, MacDonald I, et al. Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am J Physiol 1996; 271: E821–6PubMedGoogle Scholar
  30. 30.
    Mujika I, Chatard J, Lacoste L, et al. Creatine supplementation does not improve sprint performance in competitive swimmers. Med Sci Sports Exerc 1996; 28: 1435–41PubMedGoogle Scholar
  31. 31.
    Vandenberghe K, Gillis N, Van Leemputte M, et al. Caffeine counteracts the ergogenic action of muscle creatine loading. J Appl Physiol 1996; 80: 452–7PubMedGoogle Scholar
  32. 32.
    Becque M, Lochmann J, Melrose D. Effect of creatine supplementation during strength training on 1-RM and body composition [abstract]. Med Sci Sports Exerc 1997; 29: S146Google Scholar
  33. 33.
    Godly A, Yates J. Effects of creatine supplementation on endurance cycling combined with short, high-intensity bouts [abstract]. Med Sci Sports Exerc 1997; 29: S251Google Scholar
  34. 34.
    Grindstaff P, Kreider R, Bishop R, et al. Effects of creatine supplementation on repetitive sprint performance and body composition in competitive swimmers. Int J Sports Nutr 1997; 7: 330–46Google Scholar
  35. 35.
    Hamilton-Ward K, Meyers M, Skelly W, et al. Effect of creatine supplementation on upper extremity anaerobic response in females [abstract]. Med Sci Sports Exerc 1997; 29: S146Google Scholar
  36. 36.
    Prevost M, Nelson A, Morris G. Creatine supplementation enhances intermittent work performance. Res Q Exerc Sport 1997; 68: 233–40PubMedGoogle Scholar
  37. 37.
    Stout J, Echerson J, Noonan D, et al. The effects of a supplement designed to augment creatine uptake on exercise performance and fat free mass in football players [abstract]. Med Sci Sports Exerc 1997; 29: S251Google Scholar
  38. 38.
    Terrillion K, Kolkhorst F, Dolgener F, et al. The effect of creatine supplementation on two 700-m maximal running bouts. Int J Sport Nutr 1997; 7: 138–43PubMedGoogle Scholar
  39. 39.
    Vandenberghe K, Goris M, Van Hecke P, et al. Long-term creatine intake is beneficial to muscle performance during resistance training. J Appl Physiol 1997; 83: 2055–63PubMedGoogle Scholar
  40. 40.
    Bermon S, Venembre P, Sachet C, et al. Effects of creatine monohydrate ingestion in sedentary and weight-trained older adults. Acta Physiol Scand 1998; 164: 147–55PubMedGoogle Scholar
  41. 41.
    Maganaris C, Maughan R. Creatine supplementation enhances maximum voluntary isometric force and endurance capacity in resistance trained men. Acta Physiol Scand 1998; 163: 279–87PubMedGoogle Scholar
  42. 42.
    Ööpik V, Pääsuke, Timpmann S, et al. Effect of creatine supplementation during rapid body mass reduction on metabolism and isokinetic muscle performance capacity. Eur J Appl Physiol 1998; 78: 83–92Google Scholar
  43. 43.
    Snow R, McKenna M, Selig S, et al. Effect of creatine supplementation on sprint exercise performance and muscle metabolism. J Appl Physiol 1998; 84: 1667–73PubMedGoogle Scholar
  44. 44.
    Robinson TM, Sewell DA, Hultman E, et al. Role of submaximal exercise in promoting creatine and glycogen accumulation in human skeletal muscle. JApplPhysiol 1999; 87: 598–604Google Scholar
  45. 45.
    Volek JS, Duncan ND, Mazzetti SA, et al. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med Sci Sports Exerc 1999; 31: 1147–56PubMedGoogle Scholar
  46. 46.
    Ööpik V, Timpmann S, Medijainen L. Metabolic effect of creatine supplementation with or without a concomitant reduction in body weight. J Sports Sci 1999; 17: 560–1Google Scholar
  47. 47.
    Urbanski RL, Loy SF, Vincent WJ, et al. Creatine supplementation differentially affects maximal isometric strength and time to fatigue in large and small muscle groups. Int J Sports Nutr 1999; 9: 136–45Google Scholar
  48. 48.
    Earnest C, Snell P, Rodriguez R, et al. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand 1995; 153: 207–9PubMedGoogle Scholar
  49. 49.
    Thompson C, Kemp G, Sanderson A, et al. Effect of creatine on aerobic and anaerobic metabolism in skeletal muscle in swimmers. Br J Sports Med 1996; 30: 222–5PubMedGoogle Scholar
  50. 50.
    Goldberg P, Bechtel P. Effects of low dose creatine supplementation on strength, speed and power events by male athletes [abstract]. Med Sci Sports Exerc 1997; 29: S251Google Scholar
  51. 51.
    Kirksey K, Warren B, Stone M, et al. The effect of six weeks of creatine monohydrate supplementation in male and female track athletes [abstract]. Med Sci Sport Exerc 1997; 29: S145Google Scholar
  52. 52.
    Volek J, Kraemer W, Bush J, et al. Creatine supplementation enhances muscular performance during high-intensity resistance exercise. J Am Diet Assoc 1997; 97: 765–70PubMedGoogle Scholar
  53. 53.
    Kreider R, Ferreira M, Wilson M, et al. Effects of creatine supplementation on body composition, strength, and sprint performance. Med Sci Sports Exerc 1998; 30: 73–82PubMedGoogle Scholar
  54. 54.
    Francaux M, Poortmans J. Effects of training and creatine supplement on muscle strength and body mass. Eur J Appl Physiol 1999; 80: 165–8Google Scholar
  55. 55.
    Leenders N, Sherman WM, Lamb DR, et al. Creatine supplementation and swimming performance. Int J Sports Nutr 1999; 9: 251–62Google Scholar
  56. 56.
    Stone MH, Sanborn K, Smith LL, et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sport Nutr 1999; 9: 146–65PubMedGoogle Scholar
  57. 57.
    Rawson ES, Wehnert ML, Clarkson PM. Effects of 30 days of creatine ingestion in older men. Eur J Appl Physiol 1999; 80: 139–44Google Scholar
  58. 58.
    Francaux M, Demeure R, Goudemant J-F, et al. Effect of exogenous creatine supplementation on muscle PCr metabolism. Int J Sports Med 2000; 21: 1–7Google Scholar
  59. 59.
    Green AL, Simpson EJ, Littlewood JJ, et al. Carbohydrate ingestion augments creatine retention during creatine feeding in humans. Acta Physiol Scand 1996; 158: 195–202PubMedGoogle Scholar
  60. 60.
    Steenge GR, Lambourne J, Casey A, et al. The stimulatory effect of insulin on creatine accumulation in human skeletal muscle. Am J Physiol 1998; 275: E974–9PubMedGoogle Scholar
  61. 61.
    Willott CA, Young ME, Leighton B, et al. Creatine uptake in isolated soleus muscle: kinetics and dependence on sodium, but not on insulin. Acta Physiol Scand 1999; 166: 99–104PubMedGoogle Scholar
  62. 62.
    Hultman E, Soderlund K, Timmons J, et al. Muscle creatine loading in men. J Appl Physiol 1996; 81: 232–7PubMedGoogle Scholar
  63. 63.
    Ziegenfuss T, Lemon P, Rogers M, et al. Acute creatine ingestion: effects on muscle volume, anaerobic power, fluid volumes and protein turnover [abstract]. Med Sci Sports Exerc 1997; 29: S127Google Scholar
  64. 64.
    Ingwall J, Morales M, Stockdale F. Creatine and the control of myosin synthesis in differentiating skeletal muscle. Proc Natl Acad Sci USA 1972; 69: 2250–3PubMedGoogle Scholar
  65. 65.
    Ingwall J, Weiner C, Morales M, et al. Specificity of creatine in the control of muscle protein synthesis. J Cell Biol 1974; 63: 145–51Google Scholar
  66. 66.
    Ingwall J, Wildenthal K. Role of creatine in the regulation of cardiac synthesis. J Cell Biol 1976; 68: 159–63PubMedGoogle Scholar
  67. 67.
    Bessman S, Savabi F. The role of the phosphocreatine energy shuttle in exercise and muscle hypertrophy. In: Taylor A, Gollnick P, Green H, et al., editors. Biochemistry of exercise VII. Champaign (IL): Human Kinetics, 1990: 167–78Google Scholar
  68. 68.
    Flisinska-Bojanowska A. Effects of oral creatine administration on skeletal muscle protein and creatine levels. Biol Sport 1996; 13: 39–46Google Scholar
  69. 69.
    Brannon T, Adams G, Conniff C, et al. Effects of creatine loading and training on running performance and biochemical properties of rat skeletal muscle. Med Sci Sports Exerc 1997; 29: 489–95PubMedGoogle Scholar
  70. 70.
    Fry D, Morales M. A reexamination of the effects of creatine on muscle protein synthesis in tissue culture. Acta Physiol Scand 1995; 153: 207–9Google Scholar
  71. 71.
    Van Deursen J, Jap P, Heerschap A, et al. Effects of the creatine analogue β-guanidopropionic acid on skeletal muscles of mice deficient in muscle creatine kinase. Biochim Biophys Acta 1994; 1185: 327–35PubMedGoogle Scholar
  72. 72.
    Laskowski M, Chevli R, Titch C. Biochemical and ultrastructural changes in skeletal muscle induced by a creatine antagonist. Metabolism 1981; 30: 1080–5PubMedGoogle Scholar
  73. 73.
    Adams G, Haddad F, Baldwin K. Interaction of chronic creatine depletion and muscle unloading: effects on postural and locomotor muscles. J Appl Physiol 1994; 77: 1198–205PubMedGoogle Scholar
  74. 74.
    Adams G, Bodell P, Baldwin K. Running performance and cardiovascular capacity are not impaired in creatine-depleted rats. J Appl Physiol 1995; 79: 1002–7PubMedGoogle Scholar
  75. 75.
    Juhn MS, O’Kane JW, Vinci DM. Oral creatine supplementation in male collegiate athletes: a survey of dosing habits and side effects. J Am Diet Assoc 1999; 99: 593–5PubMedGoogle Scholar
  76. 76.
    Greenhaff P. Renal dysfunction accompanying oral creatine supplements [letter]. Lancet 1998; 352: 233–4PubMedGoogle Scholar
  77. 77.
    Fitch CD, Shields RP, Payne WF, et al. Creatine metabolism in skeletal muscle. J Biol Chem 1968; 243: 2024–7PubMedGoogle Scholar
  78. 78.
    Dechent P, Pouwels PJW, Wilken B, et al. Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. Am J Physiol 1999; 277: R698–704PubMedGoogle Scholar
  79. 79.
    Rogers MA, Evans WJ. Changes in skeletal muscle with aging: effects of exercise training. Exerc Sports Sci Rev 1993; 21: 65–102Google Scholar
  80. 80.
    Rawson ES, Clarkson PM, Melanson EL. The effects of oral creatine supplementation on body mass, isometric strength, and isokinetic performance in older individuals. Med Sci Sports Exerc 1998; 30: S140Google Scholar
  81. 81.
    Smith SA, Montain SJ, Matott RP, et al. Creatine supplementation and age influence muscle metabolism during exercise. J Appl Physiol 1998; 85: 1349–56PubMedGoogle Scholar
  82. 82.
    Gordon A, Hultman E, Kaijser L, et al. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res 1995; 30: 413–8PubMedGoogle Scholar
  83. 83.
    Andrews R, Greenhaff PL, Curtis S, et al. The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure. Eur Heart J 1998; 19: 617–22PubMedGoogle Scholar
  84. 84.
    Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 1997; 20: 1502–9PubMedGoogle Scholar
  85. 85.
    Pulido SM, Passaquin AC, Leijendekker WJ, et al. Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Lett 1998; 439: 357–62PubMedGoogle Scholar
  86. 86.
    Dunn JF, Frostick S, Brown S, et al. Energy status of cells lacking dystrophin: an in vivo/in vitro study of mdx mouse skeletal muscle. Biochim Biophys Acta 1991; 1096: 115–20PubMedGoogle Scholar
  87. 87.
    Sipilä I, Rapola J, Simell O, et al. Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N Engl J Med 1981; 304: 867–70PubMedGoogle Scholar
  88. 88.
    Matthews RT, Yang L, Jenkins BG, et al. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington’s disease. J Neurosci 1998; 18: 156–63PubMedGoogle Scholar
  89. 89.
    Klivenyi P, Ferrante RJ, Matthews RT, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Med 1999; 5: 347–50PubMedGoogle Scholar
  90. 90.
    Michaelis T, Wick M, Fujimori H, et al. Proton MRS of oral creatine supplementation in rats: cerebral metabolite concentrations and ischemic challenge. NMR Biomed 1999; 12: 309–14PubMedGoogle Scholar
  91. 91.
    Wick M, Fujimori H, Michaelis T, et al. Brain water diffusion in normal and creatine-supplemented rats during transient global ischemia. Magn Reson Med 1999; 42: 798–802PubMedGoogle Scholar
  92. 92.
    Ciafaloni E, Ricci E, Shanske S. MELAS: clinical features, biochemistry and molecular genetics. Ann Neurol 1992; 31: 391–8PubMedGoogle Scholar
  93. 93.
    Hagenfeldt L, von Döbeln U, Solders G, et al. Creatine treatment in MELAS [letter]. Muscle Nerve 1994; 17: 1236–7PubMedGoogle Scholar
  94. 94.
    Stöckler S, Hanefeld F, Frahm J. Creatine replacement therapy in guanidoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 1996; 348: 789–90PubMedGoogle Scholar
  95. 95.
    Stöckler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 1994; 36: 409–13PubMedGoogle Scholar
  96. 96.
    Earnest C, Almada A, Mitchell T. Influence of chronic creatine supplementation on hepatorenal function [abstract]. FASEB J 1996; 10: A790Google Scholar
  97. 97.
    Almada A, Mitchell T, Earnest C. Impact of chronic creatine supplementation on serum enzyme concentration [abstract]. FASEB J 1996; 10: A791Google Scholar
  98. 98.
    Mihic S, MacDonald JR, McKenzie S, et al. The effect of creatine supplementation on blood pressure, plasma creatine kinase, and body composition [abstract]. FASEB J 1998; 12: A652Google Scholar
  99. 99.
    Duarte JA, Neuparth MJ, Soares JMC, et al. Oral creatine supplementation and liver metabolism. Int J Sports Med 1999; 20: S50Google Scholar
  100. 100.
    Engelhardt M, Neumann G, Berbalk A, et al. Creatine supplementation in endurance sports. Med Sci Sports Exerc 1998; 30: 1123–9PubMedGoogle Scholar
  101. 101.
    Chanutin A. The fate of creatine when administered to man. J Biol Chem 1926; 67: 29–41Google Scholar
  102. 102.
    Rose WC, Ellis RH, Helming OC. The transformation of creatine into creatinine by the male and female organism. J Biol Chem 1928; 77: 171–84Google Scholar
  103. 103.
    Hyde E. Creatine feeding and creatine-creatinine excretion in males and females of different age groups. J Biol Chem 1942; 143: 301–10Google Scholar
  104. 104.
    Crim MC, Calloway DH, Margen S. Creatine metabolism in men: urinary creatine and creatinine excretions with creatine feeding. J Nutr 1975; 105: 428–38PubMedGoogle Scholar
  105. 105.
    Rossiter HB. The effect of oral creatine supplementation on the 1000m performance of competitive rowers. J Sports Sci 1996; 14: 175–9PubMedGoogle Scholar
  106. 106.
    Peyrebrune MC, Nevill ME, Donaldson FJ, et al. The effects of oral creatine supplementation on performance in single and repeated sprint swimming. J Sports Sci 1998; 16: 271–9PubMedGoogle Scholar
  107. 107.
    Poortmans JR, Auquier H, Renaut V, et al. Effects of short-term creatine supplementation on renal responses in men. Eur J Appl Physiol 1997; 76: 566–7Google Scholar
  108. 108.
    Poortmans JR, Francaux M. Renal dysfunction accompanying oral creatine supplements: reply [letter]. Lancet 1998; 352: 234PubMedGoogle Scholar
  109. 109.
    Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci 1992; 83: 367–74PubMedGoogle Scholar
  110. 110.
    Poortmans J, Francaux M. Long-term oral creatine supplementation does not impair renal function in healthy athletes. Med Sci Sports Exerc 1999; 31: 1108–10PubMedGoogle Scholar
  111. 111.
    Poortmans JR, Vanderstraeten J. Kidney function during exercise in healthy and diseased humans. Sports Med 1994; 18: 419–37PubMedGoogle Scholar
  112. 112.
    Koshy KM, Griswold E, Schneeberger EE. Interstitial nephritis in a patient taking creatine. N Engl J Med 1999; 340: 814–5PubMedGoogle Scholar
  113. 113.
    Guerrero-Ontiveros ML, Wallimann T. Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Mol Cell Biochem 1998; 184: 427–37Google Scholar

Copyright information

© Adis International Limited 2000

Authors and Affiliations

  1. 1.Physiological Chemistry, Higher Institute of Physical Education and ReadaptationFree University of BrusselsBruxellesBelgium
  2. 2.Institute of Physical Education and ReadaptationCatholic University of LouvainLouvain-la-NeuveBelgium

Personalised recommendations